Get startedLog in
    Picture of Cipla logo

    CIPLA — Cipla News Story

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareConservativeLarge CapHigh Flyer
    All News

    Brief: Fennec Pharmaceuticals Announces Settlement Agreement Resolving Pedmark Patent Litigation

    Picture of Cipla logoCipla
    16/03/2026 12:20
    March 16 (Reuters) - Fennec Pharmaceuticals Inc FENC.O:

FENNEC PHARMACEUTICALS ANNOUNCES SETTLEMENT AGREEMENT RESOLVING PEDMARK PATENT LITIGATION

FENNEC PHARMACEUTICALS INC - CIPLA BARRED FROM MARKETING GENERIC SODIUM THIOSULFATE UNTIL SEPTEMBER 1, 2033

FENNEC PHARMACEUTICALS INC: UNDER TERMS OF SETTLEMENT, LAWSUIT WILL BE DISMISSED WITH EACH PARTY BEARING THEIR OWN COSTS

Source text: ID:nGNX9TGBKl

Further company coverage: FENC.O

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Cipla

    See all news